Literature DB >> 24092455

Canine parvovirus type 2a (CPV-2a)-induced apoptosis in MDCK involves both extrinsic and intrinsic pathways.

Juwar Doley1, Lakshya Veer Singh, G Ravi Kumar, Aditya Prasad Sahoo, Lovleen Saxena, Uttara Chaturvedi, Shikha Saxena, Rajiv Kumar, Prafull Kumar Singh, R S Rajmani, Lakshman Santra, S K Palia, S Tiwari, D R Harish, Arvind Kumar, G S Desai, Smita Gupta, Shishir K Gupta, A K Tiwari.   

Abstract

The canine parvovirus type 2 (CPV-2) causes an acute disease in dogs. It has been found to induce cell cycle arrest and DNA damage leading to cellular lysis. In this paper, we evaluated the apoptotic potential of the "new CPV-2a" in MDCK cells and elucidated the mechanism of the induction of apoptosis. The exposure of MDCK cells to the virus was found to trigger apoptotic response. Apoptosis was confirmed by phosphatidylserine translocation, DNA fragmentation assays, and cell cycle analysis. Activation of caspases-3, -8, -9, and -12 and decrease in mitochondrial potential in CPV-2a-infected MDCK cells suggested that the CPV-2a-induced apoptosis is caspase dependent involving extrinsic, intrinsic, and endoplasmic reticulum pathways. Increase in p53 and Bax/Bcl2 ratio was also observed in CPV-2a-infected cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24092455     DOI: 10.1007/s12010-013-0538-y

Source DB:  PubMed          Journal:  Appl Biochem Biotechnol        ISSN: 0273-2289            Impact factor:   2.926


  9 in total

1.  Viral Nonstructural Protein 1 Induces Mitochondrion-Mediated Apoptosis in Mink Enteritis Virus Infection.

Authors:  Peng Lin; Yuening Cheng; Shanshan Song; Jianming Qiu; Li Yi; Zhigang Cao; Jianrong Li; Shipeng Cheng; Jianke Wang
Journal:  J Virol       Date:  2019-10-29       Impact factor: 5.103

2.  Poly (I:C) enhances the anti-tumor activity of canine parvovirus NS1 protein by inducing a potent anti-tumor immune response.

Authors:  Shishir Kumar Gupta; Pavan Kumar Yadav; A K Tiwari; Ravi Kumar Gandham; A P Sahoo
Journal:  Tumour Biol       Date:  2016-05-21

Review 3.  Viral genes as oncolytic agents for cancer therapy.

Authors:  Shishir Kumar Gupta; Ravi Kumar Gandham; A P Sahoo; A K Tiwari
Journal:  Cell Mol Life Sci       Date:  2014-11-19       Impact factor: 9.207

4.  Profiling of Host Cell Response to Successive Canine Parvovirus Infection Based on Kinetic Proteomic Change Identification.

Authors:  Hang Zhao; Yuening Cheng; Jianke Wang; Peng Lin; Li Yi; Yaru Sun; Jingqiang Ren; Mingwei Tong; Zhigang Cao; Jiawei Li; Jinliang Deng; Shipeng Cheng
Journal:  Sci Rep       Date:  2016-07-13       Impact factor: 4.379

5.  Molecular characterization of canine parvovirus variants (CPV-2a, CPV-2b, and CPV-2c) based on the VP2 gene in affected domestic dogs in Ecuador.

Authors:  David De la Torre; Eulalia Mafla; Byron Puga; Linda Erazo; Claudete Astolfi-Ferreira; Antonio Piantino Ferreira
Journal:  Vet World       Date:  2018-04-16

6.  Inhibitory Effects of Antiviral Drug Candidates on Canine Parvovirus in F81 cells.

Authors:  Hongzhuan Zhou; Xia Su; Lulu Lin; Jin Zhang; Qi Qi; Fangfang Guo; Fuzhou Xu; Bing Yang
Journal:  Viruses       Date:  2019-08-13       Impact factor: 5.048

7.  Porcine deltacoronavirus induces caspase-dependent apoptosis through activation of the cytochrome c-mediated intrinsic mitochondrial pathway.

Authors:  Yoo Jin Lee; Changhee Lee
Journal:  Virus Res       Date:  2018-06-22       Impact factor: 3.303

8.  Porcine parvovirus infection activates mitochondria-mediated apoptotic signaling pathway by inducing ROS accumulation.

Authors:  Xiaomin Zhao; Hailing Xiang; Xiaoyuan Bai; Naijiao Fei; Yong Huang; Xiangjun Song; Hongling Zhang; Liang Zhang; Dewen Tong
Journal:  Virol J       Date:  2016-02-16       Impact factor: 4.099

9.  Transcriptome profiling indicating canine parvovirus type 2a as a potential immune activator.

Authors:  Xu-Xu Fan; Yuan Gao; Long Shu; Yan-Quan Wei; Xue-Ping Yao; Sui-Zhong Cao; Guang-Neng Peng; Xiang-Tao Liu; Shi-Qi Sun
Journal:  Virus Genes       Date:  2016-06-23       Impact factor: 2.332

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.